LEVDIM: Levator Hiatal Dimensions and Mode of Delivery

Sponsor
St. Olavs Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05849584
Collaborator
(none)
400
2
25
200
8

Study Details

Study Description

Brief Summary

The aim of this observational study is to learn about how muscle dimensions of the pelvic floor measured during pregnancy in primigravida impact birth mecanics and mode of delivery. Tha main aims are to 1. Explore associations between mode of delivery and hiatal dimensions measured by transperineal ultrasound antenatally and 2. Explore the association between duration of 2nd stage of labour and hiatal dimensions.

A pelvic floor ultrasound examination will be performed between pregnancy week 12 and 20 and levator ani muscle hiatal dimensions will be compared between women having a normal vaginal delivery and women with emergency cesarean or operative vaginal deliveries.

Condition or Disease Intervention/Treatment Phase
  • Other: Transperineal ultrasound

Detailed Description

The women will be enrolled and examined at the 12-week routine ultrasound examination after informed consent and examined again at the 18 weeks gestation examination. The women will be examined in the supine position on a bed with knees and hips semi-flexed and abducted. Bladder and bowel should be emptied prior to the examination. They will be instructed in how to perform pelvic floor contraction and maximal Valsalva maneuver.

First, a 2D scan will be performed of one experienced clinician. The average of 3 2D levator hiatal anteroposterior measurements will be stored. Then, a 3D/4D ultrasound examination of the pelvic floor will be performed using a Voluson S10, E8 or E10 (GE healthcare, Zipf, Austria) device with a RAB 4-8 MHz curved array transducer with the acquisition angle set at 85 degrees. Offline analysis of the ultrasound volumes will be performed using the 4D view (GE Healthcare, Austria) software, blinded to all clinical data. Hiatal anteroposterior diameter will be measured in both 2D and 3D. Hiatal area and hiatal transverse diameter will be measured in the 3D volume. These measures have previously been demonstrated to have high interrater and intrarater reliability in women in this study population.

Details regarding maternal height, weight, age, ethnicity, marital status, employment, induction of labour, duration of active 2nd stage of labour, gestational length, use of epidural analgesia, indication for operative delivery (slow progress or fetal distress), mode of delivery (forceps, vacuum, cesarean section), infant birthweight, head circumference, Presentation (occiput anterior/ posterior), head station at intervention, infant gender, Apgar score, perineal trauma, postpartum hemorrhage, will be collected from electronic patient journals after delivery. The women will be informed that they may be contacted within 2 years after delivery for a follow up, but separate consent will be needed.

Participants will have a unique study number and the coupling list will be stored on a safe area at St. Olav's server.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
400 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Levator Hiatal Dimensions and Mode of Delivery
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2025
Anticipated Study Completion Date :
Oct 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Pregnant women

Other: Transperineal ultrasound
A 2D scan will be performed of one experienced clinician. The average of 3 2D levator hiatal anteroposterior measurements will be stored. Then, a 3D/4D ultrasound examination of the pelvic floor will be performed using a Voluson S10, E8 or E10 (GE healthcare, Zipf, Austria) device with a RAB 4-8 MHz curved array transducer with the acquisition angle set at 85 degrees. Offline analysis of the ultrasound volumes will be performed using the 4D view (GE Healthcare, Austria) software, blinded to all clinical data. Hiatal anteroposterior diameter will be measured in both 2D and 3D. Hiatal area and hiatal transverse diameter will be measured in the 3D volume

Outcome Measures

Primary Outcome Measures

  1. Mode of delivery [Assessed at 1 day of childbirth]

    Normal vaginal, vacuum assisted vaginal, forceps assisted vaginal or emergency cesarean delivery

  2. Levator hiatal dimensions [Measured in pregnancy week 12]

    levator hiatal anteroposterior diameter and levator hiatal area at rest measured with 2D and 3D ultrasound

  3. Levator hiatal dimensions [Measured in pregnancy week 18]

    levator hiatal anteroposterior diameter and levator hiatal area at rest measured with 2D and 3D ultrasound

Secondary Outcome Measures

  1. Duration of second stage of delivery [Assessed at 1 day of childbirth]

    Number of minutes from full dillatation of the cervix until the baby is born

  2. Pernineal tears [Assessed at 1 day of childbirth]

    Grade of perineal tear. No tear, grade 1, 2, 3, 4 or deep vaginal tear

  3. Postpartum haemorrage [Assessed at 1 day of childbirth]

    Amount in ml of postpartum haemmorage

  4. womans experience of transperineal ultrasound [Assessed at pregnancy week 12 and week 18]

    Qualitative assessment of the womans experience of transperineal ultrasound

  5. Interrater validity of ultrasound measurements [Assessed 3 months after childbirth]

    For analysis of intrarater reliability for ultrasound measurements, we will use the intraclass correlation coefficient (ICC) two-way mixed effects, absolute agreement model. To determine interrater reliability, we will use the ICC two-way random effects, absolute agreement model, applying both the mean of three raters and single measurements. [20]. The following ICC cut-offs will be applied: < 0.20 = poor reliability, 0.20-0.40 = fair reliability, 0.41-0.60 = moderate reliability, 0.61-0.80 = good reliability and > 0.80 = excellent reliability

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes

Inclusion Criteria

  • Age over 18 years

  • Ability to consent

  • Singleton pregnancy

Exclusion criteria

  • Previous deliveries > 16 weeks gestation

  • Previous pelvic floor surgery

  • Anomalies affecting the pelvic floor function (such as myelomeningocele)

  • Epilepsy, since this might influence intervention during delivery

  • Women with elective cesarean

Contacts and Locations

Locations

Site City State Country Postal Code
1 Levanger Sykehus Levanger Norway
2 st.Olavs hospital Trondheim Norway

Sponsors and Collaborators

  • St. Olavs Hospital

Investigators

  • Principal Investigator: Ingrid Volløyhaug, PhD, St. Olavs Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
St. Olavs Hospital
ClinicalTrials.gov Identifier:
NCT05849584
Other Study ID Numbers:
  • 423957
First Posted:
May 9, 2023
Last Update Posted:
May 9, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 9, 2023